Preferred Label : pretomanid;

MeSH note : nitroimidazopyran derived from 5-nitroimidazoles; a prodrug that requires activation by a bacterial F420-depedent glucose-6-phosphate dehydrogenase (Fgd) and nitroreductase to activate components that then inhibit bacterial mycolic acid and protein synthesis; structure in first source;

CISMeF synonym : PA824; PA 824;

MeSH synonym : 2-nitro-6-(4-(trifluoromethoxy)benzyloxy)-6,7-dihydro-5H-imidazo(2,1-b)(1,3)oxazine;

MeSH hyponym : PA824 cpd; PA-824;

Is substance : O;

Details


Main resources

You can consult :


https://www.ema.europa.eu/en/medicines/human/EPAR/pretomanid-fgk
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
nitroimidazoles
nitroimidazoles
orphan drug production
tuberculosis, Drug-Resistant
bedaquiline
Linezolid
administration, oral
tuberculosis, multidrug-resistant
extensively drug-resistant tuberculosis
antitubercular agents
antitubercular agents
drug therapy, combination
product surveillance, postmarketing
adult
drug interactions
pregnancy
breast feeding
drugs for treatment of tuberculosis
drug evaluation, preclinical
pretomanid
pretomanid
diarylquinolines
quinolines

---
Nous contacter.
03/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.